Christina Wang

Christina brings a wealth of experience, with over 23 years in the healthcare and pharmaceutical space, including experience clinical operations, drug licensing, business development and strategic planning.

Prior to joining Athenex, Christina was a co-founder of Choice Pharma, a full-service CRO in Asia, and was instrumental in growing the business and successfully merging Choice Pharma with Clinipace Worldwide, a global CRO, in 2014, whereupon she became Executive Vice President and Board member of Asia Pacific. She has also held various positions of leadership and increasing responsibility in Oneness Biotech Co., Ltd (Taiwan:4743), GlaxoSmithKline Biologicals, Merck Sharpe & Dohme, Bayer Healthcare and Schering-Plough.

Christina is actively supporting corporate development efforts in the Asia Pacific region, focusing on partnerships and expansion opportunities, with the goal of driving Athenex’s further growth in Asia Pacific consistent with global strategy.